GYRE Gyre Therapeutics, Inc.
$6.53▲ +7.58%
Healthcare
Other
After hours
$6.53▼ -0.15%
Oct 27, 4:00 PM ET
Volume 126.4K
Avg Volume (10D) 130.4K
Key Metrics & Fundamentals
Market Cap
$692.40M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.44 - 9.14
% vs 50 MA
-3.89%
% vs 200 MA
-6.90%
RSI-14
49.6
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.40
Free Cash Flow
-$18.01M
Gross Rev
$29.11M
Gross Profit
$26.90M
EBITDA
-$12.01M
COGS
$2.21M
Operating Exp
$40.76M
Operating Income
-$13.86M
EBIT
-$13.86M
Pretax Income
-$14.43M
Net Income
-$10.61M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire · Sep 3, 2026 7:00 AM ET
Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 7, 2026 8:20 AM ET
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
GlobeNewswire · Aug 7, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GYRE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.